跳转到内容

NCI-60：修订间差异

编辑链接
维基百科，自由的百科全书
以互动方式浏览历史
←上一版本下一版本→
删除的内容 添加的内容
可视化wikitext
第48行： 第48行：
! 细胞系 !! 性别 !! 倍增时间 !! 文献 !! 外部链接
! 细胞系 !! 性别 !! 倍增时间 !! 文献 !! 外部链接
|-
|-
| [[HCT 166]] || 男 || 17.4h || <ref name=a>{{cite journal |last1=Rajput |first1=A |last2=Dominguez San Martin |first2=I |last3=Rose |first3=R |last4=Beko |first4=A |last5=Levea |first5=C |last6=Sharratt |first6=E |last7=Mazurchuk |first7=R |last8=Hoffman |first8=RM |last9=Brattain |first9=MG |last10=Wang |first10=J |title=Characterization of HCT116 human colon cancer cells in an orthotopic model. |journal=The Journal of surgical research |date=2008-06-15 |volume=147 |issue=2 |pages=276-81 |doi=10.1016/j.jss.2007.04.021 |pmid=17961596 |url=https://pubmed.ncbi.nlm.nih.gov/17961596-characterization-of-hct116-human-colon-cancer-cells-in-an-orthotopic-model/ |accessdate=2019-12-31 |author= |archive-url=https://web.archive.org/web/20191231075640/https://pubmed.ncbi.nlm.nih.gov/17961596-characterization-of-hct116-human-colon-cancer-cells-in-an-orthotopic-model/ |archive-date=2019-12-31 |dead-url=yes }}</ref> || [https://www.cellosaurus.org/CVCL_0291 CVCL_0291]
| [[HCT 166]] || || 17.4h || || [https://www.cellosaurus.org/CVCL_0291 CVCL_0291]
|-
|-
| [[HT-29]] || || 19.5h || || [https://www.cellosaurus.org/CVCL_0320 CVCL_0320]
| [[HT-29]] || 女 || 19.5h || <ref name=one>{{cite book|title=The Impact of Food Bioactives on Health|first1=D|last1=Martínez-Maqueda|display-authors=etal|doi=10.1007/978-3-319-16104-4_11|pmid=29787047|publisher=Springer|pages=113–124|date=2015|chapter=HT29 Cell Line|isbn=978-3-319-15791-7}}</ref> || [https://www.cellosaurus.org/CVCL_0320 CVCL_0320]
|-
|-
|}
|}

2024年1月26日 (五) 13:24的版本

NCI-60是美国国家癌症研究所（National Cancer Institute，NCI）列出的60种人类癌症细胞系的列表，用于抗癌药物筛选等科学研究[1]。

细胞系

白血病

细胞系 性别 倍增时间 文献 外部链接
CCRF-CEM 女 26.7h [2] CVCL_0207
HL-60 女 28.6h [3] CVCL_0002
K-562 女 19.6h [4][5] CVCL_0004
MOLT-4 男 27.9h [6] CVCL_0013
RPMI-8226 男 33.5h [7] CVCL_0014
SR-786 男 28.7h [8] CVCL_1711

非小细胞肺癌

细胞系 性别 倍增时间 文献 外部链接
A549 男 22.9h [9] CVCL_0023
EKVX 43.6h CVCL_1195
HOP-62 39h CVCL_1285
HOP-92 79.5h CVCL_1286
NCI-H226 61h CVCL_1544
NCI-H23 33.4h CVCL_1547
NCI-H322M 35.3h CVCL_1557
NCI-H460 17.8h CVCL_0459
NCI-H522 38.2h CVCL_1567

结直肠癌

细胞系 性别 倍增时间 文献 外部链接
HCT 166 男 17.4h [10] CVCL_0291
HT-29 女 19.5h [11] CVCL_0320

中枢神经系统

细胞系 性别 倍增时间 文献 外部链接
[[]] h

黑色素瘤

细胞系 性别 倍增时间 文献 外部链接
[[]] h

卵巢癌

细胞系 倍增时间 文献 外部链接
[[]] h

肾癌

细胞系 性别 倍增时间 文献 外部链接
[[]] h

前列腺癌

细胞系 性别 倍增时间 文献 外部链接
PC-3 男 27.1h [12] CVCL_0035
DU145 男 32.3h [13] CVCL_0105

乳腺癌

细胞系 倍增时间 文献 外部链接
[[]] h

參考資料

  1. ^ NCI-60 Human Tumor Cell Lines Screen | Discovery & Development Services | Developmental Therapeutics Program (DTP). dtp.cancer.gov. 
  2. ^ FOLEY, GE; LAZARUS, H; FARBER, S; UZMAN, BG; BOONE, BA; MCCARTHY, RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. April 1965, 18 (4): 522–9. PMID 14278051. S2CID 32647486. doi:10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j 可免费查阅. 
  3. ^ Gallagher, R; Collins, S; Trujillo, J; McCredie, K; Ahearn, M; Tsai, S; Metzgar, R; Aulakh, G; Ting, R; Ruscetti, F; Gallo, R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.. Blood. September 1979, 54 (3): 713–33. PMID 288488. doi:10.1182/blood.V54.3.713.713 可免费查阅. 
  4. ^ Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. March 1975, 45 (3): 321–334. PMID 163658. doi:10.1182/blood.V45.3.321.321 可免费查阅. 
  5. ^ Drexler HG. The Leukemia-Lymphoma Cell Line Factsbook. San Diego: Academic Press. 2000. 
  6. ^ Minowada, J; Onuma, T; Moore, GE. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.. Journal of the National Cancer Institute. September 1972, 49 (3): 891–5. PMID 4567231. 
  7. ^ Matsuoka, Y; Moore, GE; Yagi, Y; Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.. Proceedings of the Society for Experimental Biology and Medicine. August 1967, 125 (4): 1246–50. PMID 6042436. S2CID 9643262. doi:10.3181/00379727-125-32327. 
  8. ^ Su, IJ; Balk, SP; Kadin, ME. Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies.. The American Journal of Pathology. August 1988, 132 (2): 192–8. PMC 1880737 可免费查阅. PMID 2456698. 
  9. ^ Giard, DJ; Aaronson, SA; Todaro, GJ; Arnstein, P; Kersey, JH; Dosik, H; Parks, WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.. Journal of the National Cancer Institute. 1973-11, 51 (5): 1417–23. PMID 4357758. doi:10.1093/jnci/51.5.1417. 
  10. ^ Rajput, A; Dominguez San Martin, I; Rose, R; Beko, A; Levea, C; Sharratt, E; Mazurchuk, R; Hoffman, RM; Brattain, MG; Wang, J. Characterization of HCT116 human colon cancer cells in an orthotopic model.. The Journal of surgical research. 2008-06-15, 147 (2): 276–81 [2019-12-31]. PMID 17961596. doi:10.1016/j.jss.2007.04.021. （原始内容存档于2019-12-31）. 
  11. ^ Martínez-Maqueda, D; et al. HT29 Cell Line. The Impact of Food Bioactives on Health. Springer. 2015: 113–124. ISBN 978-3-319-15791-7. PMID 29787047. doi:10.1007/978-3-319-16104-4_11. 
  12. ^ Kaighn, ME; Narayan, KS; Ohnuki, Y; Lechner, JF; Jones, LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3).. Investigative urology. 1979-07, 17 (1): 16–23 [2020-01-13]. PMID 447482. （原始内容存档于2020-01-13）. 
  13. ^ Stone, KR; Mickey, DD; Wunderli, H; Mickey, GH; Paulson, DF. Isolation of a human prostate carcinoma cell line (DU 145).. International journal of cancer. 1978-03-15, 21 (3): 274–81. PMID 631930. doi:10.1002/ijc.2910210305. 
检索自“https://zh.wikipedia.org/w/index.php?title=NCI-60&oldid=80667973”